Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|70|2|154-158

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.2, 2006-05, pp. : 154-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of second‐line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1620-1627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic and Clinical Phase II Trial of Imatinib in Patients with Impaired Liver Function and Advanced Hepatocellular Carcinoma

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 363-371

Karger

Access to resources Recommend Favorite

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Oncology, Vol. 85, Iss. 1, 2013-07 ,pp. : 44-52

Karger

Access to resources Recommend Favorite

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 175-181

Karger

Access to resources Recommend Favorite

Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298)

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 303-309

Karger

Access to resources Recommend Favorite